HomeXBIT • NASDAQ
add
XBiotech Inc
Nakaraang pagsara
$3.04
Sakop ng araw
$2.93 - $3.05
Sakop ng taon
$2.65 - $9.45
Market cap
89.33M USD
Average na Volume
55.47K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | — | — |
Gastos sa pagpapatakbo | 8.75M | 1.87% |
Net na kita | -10.51M | -126.71% |
Net profit margin | — | — |
Kita sa bawat share | — | — |
EBITDA | -8.31M | -1.91% |
Aktuwal na % ng binabayarang buwis | 0.39% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 172.68M | -13.67% |
Kabuuang asset | 199.09M | -12.14% |
Kabuuang sagutin | 16.82M | 116.57% |
Kabuuang equity | 182.27M | — |
Natitirang share | 30.49M | — |
Presyo para makapag-book | 0.51 | — |
Return on assets | -10.70% | — |
Return on capital | -11.08% | — |
Cash Flow
Net change in cash
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -10.51M | -126.71% |
Cash mula sa mga operasyon | -6.54M | -90.50% |
Cash mula sa pag-invest | -84.00K | 26.96% |
Cash mula sa financing | 283.00K | — |
Net change in cash | -10.44M | -381.60% |
Malayang cash flow | -5.72M | -88.39% |
Tungkol
XBiotech Inc. is a clinical-stage biopharmaceutical company based in Austin, Texas. It specializes in the research and development of human-derived antibody therapeutics for multiple diseases, including cancer, rheumatological, and infectious diseases. Wikipedia
Itinatag
2005
Headquarters
Website
Mga Empleyado
92
